Petmed Express ( (PETS) ) has released a notification of late filing.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
PetMed Express, Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the period ending September 30, 2025. The delay is primarily due to the need to first complete and file the previous quarter’s report, which was postponed due to an investigation by the company’s Audit Committee. The company expects to file the delayed report within five calendar days following the due date. Preliminary financial results indicate a significant decrease in net sales compared to the same period last year, with sales estimated between $43.4 million and $44.5 million for the three-month period. The company is also analyzing a potential goodwill impairment charge. PetMed Express is actively working on compliance, with the notification signed by Douglas Krulik, Chief Accounting Officer and Interim Principal Financial Officer.
The most recent analyst rating on (PETS) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Petmed Express stock, see the PETS Stock Forecast page.
Spark’s Take on PETS Stock
According to Spark, TipRanks’ AI Analyst, PETS is a Neutral.
Petmed Express faces significant financial and technical challenges. Declining revenues and profitability issues weigh heavily on the stock, compounded by weak technical indicators. The negative P/E ratio and lack of dividend yield further detract from its valuation appeal. The company’s strong balance sheet is a positive, but it is overshadowed by cash flow concerns.
To see Spark’s full report on PETS stock, click here.
More about Petmed Express
Average Trading Volume: 111,248
Technical Sentiment Signal: Sell
Current Market Cap: $54.85M
For a thorough assessment of PETS stock, go to TipRanks’ Stock Analysis page.

